You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Bulk Pharmaceutical API Sources for ELIMITE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for ELIMITE

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free 442748_SUPELCO ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 47956_SUPELCO ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-003-933-021 ⤷  Get Started Free
Vitas-M Laboratory ⤷  Get Started Free STL135986 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS005746953 ⤷  Get Started Free
TimTec ⤷  Get Started Free ST50975270 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Last updated: July 30, 2025

lk Active Pharmaceutical Ingredient (API) Sources for: ELIMITE


Introduction
Elimite, with the generic name permethrin, is a topical antiparasitic agent primarily used to treat scabies and certain lice infestations. As a critical component in dermatological therapeutics, the supply chain for permethrin API directly impacts manufacturing, regulatory compliance, and global availability. The sourcing of permethrin API involves multiple considerations, including quality standards, regulatory approvals, and geopolitical factors. This article explores the primary sources of bulk permethrin API for Elimite, analyzing their geographic distribution, manufacturing reputation, and regulatory credentials, to aid pharmaceutical professionals in strategic procurement planning.


Overview of Permethrin API Production

Permethrin is a synthetic pyrethroid modeled after natural pyrethrins extracted from Chrysanthemum flowers. Its synthesis involves complex organic reactions, requiring stringent quality control measures to meet pharmacopeial standards such as USP, EP, and BP. Given its widespread use, multiple manufacturers worldwide produce permethrin API, varying in scale, regulatory approvals, and compliance certifications.

Key criteria for API sourcing include:

  • Good Manufacturing Practice (GMP) compliance
  • Certification of analytical methods
  • Regulatory approval status in major markets (FDA, EMA, etc.)
  • Consistency in batch quality and supply reliability

Major Geographic Regions Supplying Permethrin API

1. China
China remains the dominant global source of permethrin API, accounting for a significant share of supply due to its expansive chemical manufacturing infrastructure. Major Chinese API producers such as Zhejiang Huahai Pharmaceutical and Hubei Sanonda Co., Ltd., have established GMP-compliant facilities capable of meeting international standards. These manufacturers often possess certifications from regulatory authorities like the Chinese National Medical Products Administration (NMPA), and some have achieved approvals for exports to the US and Europe.

The Chinese API market offers advantages of cost competitiveness and scalable production capacity. However, buyers must verify supplier GMP status, regulatory approvals, and quality certifications, as quality variance exists among some producers. Due diligence, including site audits and analytical testing, is recommended before entering long-term contracts.

2. India
India's pharmaceutical sector boasts several API producers specializing in pyrethroids, including Permethrin. Companies like Aarti Industries and JSC Russian Chemicals (with manufacturing facilities in India) maintain GMP compliance and often hold ISO certifications. These producers cater primarily to the domestic market but also serve exports to regulatory agencies worldwide.

Indian suppliers benefit from stringent adherence to quality standards aligned with the Drug Consultations and the Drugs and Cosmetics Act. The Indian government has promoted API manufacturing through schemes like the Pharma Vision 2020, strengthening both production capacity and quality assurance. Consequently, Indian permethrin API offers a reliable alternative, appealing to buyers prioritizing quality and regulatory compliance.

3. Eastern Europe and Russia
Russian and Eastern European chemical companies, such as Tula Chemical Plant (Russia), also produce permethrin API. Historically, these entities supplied the European market, benefiting from proximity and established trade relations. Many adhere to EU Good Manufacturing Practice (EU-GMP) standards and possess certifications from EMA accreditation bodies.

Given geopolitical considerations and regional nuances in regulatory pathways, these sources often serve niche markets but remain significant for regional pharmaceutical manufacturers. Buyers should consider political stability and export regulations as part of their sourcing strategy.

4. Southeast Asia and Other Emerging Markets
Micro, small, and medium-sized manufacturing units in Southeast Asia, including Vietnam and Indonesia, produce permethrin API. These suppliers generally serve the domestic and nearby markets but have been expanding their export footprint. Regulatory oversight and quality assurance may vary, warranting rigorous supplier qualification processes for international buyers.


Regulatory and Quality Certification Landscape

Reliable sourcing necessitates engagement with suppliers holding recognized certifications:

  • GMP Certification: Ensures manufacturing consistency and quality. Internationally recognized agencies include FDA (USA), EMA (Europe), and the respective national agencies.
  • Certifications: ISO 9001 and ISO 14001 certifications indicate quality and environmental management systems.
  • Pharmacopoeial Compliance: USP, EP, or BP compliance certifies that APIs meet internationally recognized monographs.

Suppliers with a history of regulatory audits and compliance documentation provide added assurance of batch-to-batch consistency, critical for finished dosage form manufacturing.


Supply Chain Considerations and Risks

  • Quality Variations: Variability in API purity, residual solvents, and impurity profiles can affect product efficacy and safety.
  • Regulatory Approvals: APIs from non-approved or uncertified suppliers pose regulatory risks, potentially delaying product registration or market access.
  • Geopolitical Factors: Trade tensions, tariffs, and export restrictions can disrupt supply chains, especially from certain Chinese or Russian suppliers.
  • Capacity Constraints: Increased global demand for permethrin API, driven by vector control and parasitic disease management, may impact supply continuity.

Navigating these risks requires comprehensive supplier audits, quality agreements, and diversified sourcing strategies.


Key Global API Suppliers of Permethrin (Summary Table)

Region Notable Manufacturers Certifications Notes
China Zhejiang Huahai Pharmaceutical, Hubei Sanonda GMP, ISO 9001 Large-scale, cost-effective
India Aarti Industries, JSC Russian Chemicals (India operations) GMP, ISO Emphasis on quality, export-ready
Russia/Eastern Europe Tula Chemical Plant EU-GMP, ISO Regional supplies, stable quality
Southeast Asia Various micro-manufacturers Varies Niche suppliers, verification needed

Conclusion

Securing a reliable, high-quality source of permethrin API is central to the continued success of Elimite. While Chinese and Indian manufacturers dominate global supply, due diligence should underpin procurement decisions, emphasizing GMP compliance, regulatory approvals, and consistency. Balancing cost, quality, and geopolitical risk is key to establishing a resilient supply chain capable of supporting sustained product manufacturing and distribution.


Key Takeaways

  • The Chinese API sector supplies the majority of permethrin, but quality verification remains imperative.
  • Indian manufacturers provide a competitive balance of quality and cost, with strong regulatory compliance.
  • Regulatory certifications such as GMP and internationally recognized pharmacopoeial standards are essential benchmarks.
  • Supply chain risks include quality variability, geopolitical factors, and capacity constraints, necessitating diversified sourcing.
  • Regular audits, supplier qualification, and strategic inventory management are critical for uninterrupted supply.

FAQs

1. Are permethrin APIs from China FDA-approved for pharmaceutical use?
While many Chinese API manufacturers hold GMP certifications recognized by local or international authorities, FDA approval of the API itself is not always required unless specifically registered with the FDA. Buyers should confirm GMP certification, analytical data, and regulatory compliance to ensure suitability for pharmaceutical manufacturing in regulated markets.

2. How can I verify the quality of permethrin API from a new supplier?
Perform comprehensive supplier qualification, including audit visits, review of quality certifications, analytical data verification, and batch testing. Engaging third-party testing laboratories for independent quality assessments further mitigates risks.

3. Is permethrin API from India compliant with European standards?
Many Indian API producers comply with EU-GMP standards and produce APIs conforming to European pharmacopoeial monographs, facilitating regulatory approval in Europe. Confirm supplier certifications and request batch documentation to validate compliance.

4. What are the geopolitical risks associated with sourcing permethrin APIs from China?
Trade tensions, export restrictions, and tariffs can impact supply continuity from China. Maintaining relationships with multiple suppliers and monitoring regulatory developments are essential mitigation strategies.

5. Are there alternative sources of permethrin API in emerging markets?
Yes, Southeast Asian manufacturers produce permethrin API for local and regional markets. However, rigorous qualification and regulatory vetting are necessary to ensure compliance with international standards before utilizing these sources.


References

[1] U.S. Pharmacopeia. Permethrin Monograph.
[2] European Pharmacopoeia. Permethrin Monograph.
[3] Chinese NMPA Certification Data.
[4] Indian Pharmacopoeia Commission. Permethrin API Standards.
[5] Market analysis reports on pyrethroid APIs and supply chain dynamics.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.